UBS: Optimistic about SUNART RETAIL's (06808) transformation plan, maintains target price of 2.4 Hong Kong dollars.
The company believes that through reducing the number of SKUs, shrinking store size, and accelerating the launch of new products, the product strength of Carrefour is expected to improve.
UBS released a research report stating that it is optimistic about SUNART RETAIL's (06808) transformation plan, but due to intense competition in the delivery platform market and the transformation and upgrade of offline food retail stores, the bank remains cautious about the short-term prospects. The bank maintains the stock's target price at 2.4 Hong Kong dollars and rates it as a "buy". The bank believes that by reducing the number of SKUs and the size of stores, and accelerating the launch of new products, the product strength of Sun Art has the potential to improve. The management's goal is to increase the sales percentage of own-brand products from the current 3% to 10% within three years, and to reach 20% in the long term.
Related Articles

Jiangsu Hengrui Pharmaceuticals (01276) has adjusted 20 products/indications to the new national medical insurance list. Among them, 10 products are included for the first time.

CHINA BOTON (03318) will be suspended from trading starting December 8th for a short period, awaiting the announcement of a significant sale transaction.

GMTEight List of A-share restricted sales and lifting restrictions | December 8th
Jiangsu Hengrui Pharmaceuticals (01276) has adjusted 20 products/indications to the new national medical insurance list. Among them, 10 products are included for the first time.

CHINA BOTON (03318) will be suspended from trading starting December 8th for a short period, awaiting the announcement of a significant sale transaction.

GMTEight List of A-share restricted sales and lifting restrictions | December 8th






